Portfolio comparison
Gilead Sciences Inc vs Curevac SE
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Gilead Sciences Inc
Patents indexed
3
Year range
2013 – 2017
Most recent
2017
biotechpharmaceutical
Top Patents3 enriched
US 8592397· 2013
How Gilead Made a Stable HIV Pill Combining Two Medicines
US 9216996· 2015
Gilead's Chemical Compounds for Treating HIV Infections
US 9744181· 2017
How Gilead Stabilized the HIV Combination Pill Truvada
Activity by Decade
2010s3
Company B
Curevac SE
Patents indexed
2
Year range
2024
Most recent
2024
biotechpharmaceuticaloncologygene_editingimmunotherapy
Top Patents2 enriched
US 12048738· 2024
Using mRNA to Teach the Body to Fight Prostate Cancer
US 12083190· 2024
How an mRNA Vaccine Teaches Your Body to Fight Rabies
Activity by Decade
2020s2
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.